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Plasma lipid levels in patients with acute bacterial infections
Mohammad NASSAJI1, Raheb GHORBANI2

Aim: To assess the impact of acute bacterial infections on plasma lipid levels and to determine the value of plasma lipid
measurements in the diagnosis of acute bacterial infection.
Materials and methods: A cross-sectional study was conducted involving 112 patients with acute bacterial infections
admitted in hospital and 112 healthy individuals as controls. Levels of total cholesterol, high-density lipoprotein
cholesterol, low-density lipoprotein, and triglycerides were measured in blood samples of all subjects. Mean levels of
serum lipids were compared in both groups.
Results: Both groups were matched based on age (P = 0.10), sex (P = 0.789), BMI (P = 0.515), and history of diabetes
mellitus (P = 0.231). Compared with control subjects, in patients with acute bacterial infections, significantly lower
levels of total cholesterol (P = 0.013) and high-density lipoprotein cholesterol (P = 0.001) were found. There was no
statistically significant differences in triglycerides (P = 0.194) and low-density lipoprotein (P = 0.075) serum levels
between patients and controls.
Conclusion: These results suggested that acute bacterial infections are associated with decreased serum cholesterol and
high-density lipoprotein level. Therefore plasma lipids levels may serve as indicators of acute bacterial infections.
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Introduction
Lipids, such as cholesterol and triglycerides, are insoluble in plasma. Circulating lipid is carried
in lipoproteins that transport the lipid to various tissues for energy utilization, lipid deposition,
steroid hormone production, and bile acid formation (1). Plasma lipoproteins are divided into
5 major classes based on their relative density: chylomicrons, very low-density lipoprotein
(VLDL), intermediate-density lipoprotein (IDL), low-density lipoprotein (LDL), and high-density
lipoprotein (HDL) (2). Besides their role in lipid transport, lipoproteins participate in innate
immunity, which is the first line of host defense against invading microorganisms (3). In addition,
anti-inflammatory effects of lipoproteins, especially HDL, have been demonstrated both in vitro
and in vivo studies (4). Circulating lipoproteins bind and detoxify lipopolysaccharide and toxins
of gram-negative and lipoteichoic acid of gram-positive bacteria (5,6).
Infection and inflammation produce a variety of profound changes in plasma lipid and
lipoprotein concentration, composition, and function. Many of the changes are induced by
cytokines that are released during infections and inflammations (7,8).
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Lipids and bacterial infections

In patients with infection, decreases in the
serum levels of total cholesterol (TC), LDL, and
HDL and increase of serum triglyceride (TG)
have been reported in most studies. These changes
were independent of the underlying disease or
infectious agents (9,10). The effects of infections on
TG metabolism are similar in all animals, whereas
changes in cholesterol metabolism differ between
rodents and primates. In rodents, there is an
increase in serum total cholesterol levels and hepatic
cholesterol synthesis, whereas nonhuman primates
and humans have either no change or a decrease in
serum cholesterol and LDL levels. HDL levels are
decreased in both rodents and primates during acute
illness. The mechanisms underlying this species
difference are not known (11,12).
Finally, infections produce alterations in the
composition and function of lipoproteins, including
changes in sphingolipid concentrations, decreased
reverse cholesterol transport, and increased oxidation
of lipids (8).
It has been proposed that the changes in lipids and
lipoproteins metabolism that occur during infection
induce anti-inflammatory effects that contribute to
the host defense (13).
Markers that will be able to differentiate the
inflammatory response of infection from other types
of inflammations would be helpful. There are still
controversies regarding the change in plasma lipids
during acute infections. The diagnostic accuracy of
plasma lipid routine measurements for infection
needs further investigation. Moreover, whether in
patients with acute bacterial infections plasma lipids
could help to differentiate bacterial from nonbacterial
diseases remains unknown. In most previous studies
one bacterial infection or patients with severe
infection were evaluated and most of these studies did
not include a control group. Therefore, we designed
this study to investigate the change in concentrations
of TC, TG, HDL, and LDL in patients with acute
bacterial infections and compare them with those of
healthy subjects. We hypothesized that plasma lipids
can serve as a marker to differentiate acute bacterial
infections from other acute conditions.
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Materials and methods
Adult patients older than 16 years with acute bacterial
infections admitted to Fatemieh hospital in Semnan
Province of Iran, between June and December of
2009, were considered for inclusion in the study.
Acute bacterial infections included in this study
were pneumonia, acute pyelonephritis, bacterial
dysentery, and cellulites. The control group was
selected from the healthy adult population. Informed
written consent was obtained from all subjects before
enrollment. The study protocol was approved by
the Research Council and Ethical Committee of the
Semnan University of Medical Science.
Both groups were matched based on age, sex,
body mass index (BMI), and diabetes mellitus.
Individuals with a history of hyperlipidemia,
diseases that can cause secondary hyperlipidemia,
concomitant acute illness, and history of infection
or who received treatment with lipid-lowering
drugs within the previous month were excluded.
Acute bacterial infections were diagnosed according
to standard clinical, laboratory, and radiographic
criteria by a board-certified specialist in infectious
diseases. Baseline assessment included collection of
demographic data, BMI, history of diabetes mellitus
and, in patients, the type of bacterial infection.
In all subjects, the day after admission, an
overnight fasting venous blood sample was taken and
serum levels of total cholesterol, triglyceride, HDL,
and LDL were measured with a colorimetric method
(Biomerieux photometer, France). Normal levels
based on the kit used were: cholesterol 130-200, TG
<150, HDL 40-70, LDL<130. Mean levels of serum
lipids were compared between the 2 groups.
Statistical analysis was performed by chi-square,
Student’s t test, multivariate analysis and Bonferroni
test using SPSS for Windows version 16.0. P values of
less than 0.05 were considered statistically significant.
Results
A total of 112 patients with bacterial infections who
fulfilled the inclusion criteria and the same number of
controls were enrolled. Of the 112 patients included,
41 (36.6%) had pneumonia, 26 (23.2%) bacterial
dysentery, 24 (21.4%) acute pyelonephritis, and 21
(18.7%) cellulitis. The time from onset of symptoms
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until sampling in 93.8% was less than 48 h and, in
6.2% of patients, it was 48-96 h.
Sex, BMI, history of diabetes mellitus, and mean
(± SD) age for patients and the control group are
listed in Table 1. There were no significant differences
in age, sex, BMI, and history of diabetes mellitus.
Multivariate analysis showed that mean serum
levels of cholesterol (P = 0.013) and HDL-C (P =
0.001) were significantly lower in patients compared
to controls. However, there was no significant
difference between mean serum levels of triglyceride
(P = 0.194) or LDL (P = 0.075) between the groups
(Table 2).

Discussion
In the present study, we found that levels of cholesterol
and HDL were significantly lower in patients with
acute bacterial infection than they were in healthy
control subjects. Levels of TG and LDL tended to
be lower in patients but did not show significant
differences compared with controls.
The exact pathophysiology underlying the change in
the level of serum lipids in severe illness and infection
has never been fully understood. Different mechanisms,
including imbalance between synthesis and utilization
of plasma lipids, usage of lipids to restore damaged
cell membranes, and interaction of cytokines and

Table 1. Characteristics of patients with bacterial infections and control groups.
Study group
Characteristic

Case
Mean ± SD

*

Control

P-value

%

Mean ± SD

%

Sex
Female

-

52.7

-

50.9

0.789

+

-

6.3

-

10.7

0.231

-

2.7
42.9
41.1
13.4

0.515

Diabetes mellitus

Body mass index
<18.5
18.5-24.9
25-29.9
30≤
Age

-

3.6
39.3
36.6
20.5

53.9 ± 20.3

49.9 ± 15.1

0.100

* SD: Standard deviation

Table 2. Mean ± standard error (SE) and difference of serum lipids between patients with acute bacterial infections
and control group.
Study group
Serum lipid

Case
Mean ± SE

Control
*

Mean ± SE

Difference between 2 groups
Mean ± SE

P-Value

95% CI**

TG

133.3 ± 13.5

158.0 ± 13.6

24.7 ± 18.9

0.194

(–12.6, 62.0)

Cholesterol

147.5 ± 6.4

170.0 ± 6.3

22.2 ± 8.9

0.013

(4.6, 39.7)

HDL

41.2 ± 0.8

45.2 ± 0.8

4.0 ± 1.1

0.001

(1.8, 6.3)

LDL

80.1 ± 5.4

93.6 ± 5.4

13.5 ± 7.6

0.075

(–1.4, 28.4)

* Standard error

**CI: Confidence interval
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Lipids and bacterial infections

bacterial toxins with lipids have been discussed (1416). Several clinical and experimental studies suggest
that high circulating levels of different cytokines may
be responsible for the decrease in cholesterol levels
in acute illnesses (17). Furthermore, one important
mechanism leading to the decrease in HDLC is
consumption through bacterial substances, particularly
lipopolysaccharide (LPS) and other endotoxins (6,18).
Another reason for the decreased serum HDL levels
might be elevated secretory phospholipase A2 activity
and serum amyloid A levels, which increase during
acute bacterial infections and result in increased
catabolism of HDL-C (19). Finally, lipoproteins may be
redistributed from the intravascular to the extravascular
compartment due to inflammation-induced capillary
leakage. Preliminary data indicate that, due to the high
molecular mass of lipoprotein, in normal situations,
only small amounts of lipoproteins can be found in the
extravascular fluids (3,17).
Our findings confirm most other studies reporting
that cholesterol and HDL levels decrease in acute
infections. In accordance with our findings, Alvarez
et al. found that concentration of total cholesterol,
HDL and apoproteins decreased during sepsis (10).
Similarly, another study showed that HDL-C and total
cholesterol levels were lower in critically ill infected
patients than they were in non-infected patients (20).
Patients with community-acquired pneumonia have
had significantly lower total cholesterol and HDL-C
in Gruber et al.’s study (21). Vermont et al. reported
extremely low levels of total serum cholesterol and
HDL in children with severe meningococcal disease
who are in the initial phase (22).
In contrast to earlier studies that described
hypertriglyceridemia during infections (10,23,24),
our study showed no significant difference in
triglyceride concentrations in patients with bacterial
infections compared to normal subjects. Kerttula
et al. found a low triglyceride level in patients with
bacterial pneumonia (25). In another study, lower
plasma level of triglyceride was reported in patients
with severe sepsis (17). In contrast, one study showed
slightly elevated triglyceride level in children with
pharyngitis; however, no significant difference was
observed compared to healthy children (26). Similarly,
Gordon et al. reported in their study that, in critically
ill patients, the mean triglyceride concentration was
468

higher in patients with an infection compared to
patients without infection, but these differences were
not statistically significant (27). In another study no
significant difference was seen in the serum TG level
in critically ill infected patients when compared with
non-infected critically ill patients (20). This difference
in findings may be due to the type of disease being
evaluated and the number of patients.
Some studies showed that plasma LDL-C levels
are reduced during infection and inflammation
(17,21,22). This is thought to be caused by the host
response to infection and inflammation, which might
induce LDL-C oxidation resulting in lower serum
LDL-C levels (7). In our study, the level of LDL was
lower in patients but this decrease was not significant.
The limitations of our study must be pointed
out. First, unfortunately, we do not know the preadmission plasma lipid values of our patients. Second,
we did not follow our patients and so we could
not determine how long this change in lipid levels
persisted. Third, the number of patients enrolled in
the study was low. A study with a larger group of
patients is recommended.
It was suggested in some studies that increasing
the low plasma lipoprotein concentrations that
are common during acute illness was a therapeutic
option for preventing and treating the clinical
syndromes associated with infection (4,16), which
warrants further study.
If confirmed in further studies with a larger
sample and combined with other clinical and
laboratory markers, measurement of plasma lipids,
especially cholesterol and HDL, may allow clinicians
to target patients with acute bacterial infections. On
the other hand, physicians should be reminded that
measurement of lipid values in patients with bacterial
infections should not be used for cardiovascular risk
prediction, since circulating levels of TC and HDL-C
may be false-low in such patients.
More studies are needed to explore the potential
of plasma lipids compared to alternative measures
in monitoring infection and therapy response in
patients with bacterial infections. Furthermore, it is
recommended that these changes be followed after
recovery from infections and serum lipids in patients
with bacterial and viral infections be compared.
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Conclusion
Low levels of plasma lipids, particularly cholesterol
and HDL, may point to acute bacterial infection.
This property might be due to an association with the

acute-phase response. Therefore decreased plasma
levels of cholesterol and HDL may serve as indicators
of acute bacterial infections.

References
1.

Mahley R, Wisgraber K, Bersot T. Disorders of lipid
metabolism. In: Kronenberg H, Melmed S, Polonsky K,
Reedlarsen P, editors. Williams Textbook of Endocrinology.
11th ed. Philadelphia: Saunders; 2008. p.1589-1610.

16.

Gordon BR, Parker TS, Levine DM, Saal SD, Wang JC, Sloan BJ
et al. Relationship of hypolipidemia to cytokine concentrations
and outcomes in critically ill surgical patients. Crit Care Med
2001; 29: 1563-8.

2.

Kwiterovich PO Jr. The metabolic pathways of high-density
lipoprotein, low-density lipoprotein, and triglycerides: a
current review. Am J Cardiol 2000; 21: 5-10. Review

17.

van Leeuwen HJ, Heezius EC, Dallinga GM, van Strijp JA,
Verhoef J, van Kessel KP. Lipoprotein metabolism in patients
with severe sepsis. Crit Care Med 2003; 31: 1359-66.

3.

Murch O, Collin M, Hinds CJ, Thiemermann C. Lipoproteins
in inflammation and sepsis. I. Basic science. Intensive Care
Med 2007; 33: 13-24.

18.

4.

Khovidhunkit W, Kim M, Memon RA, Shigenaga JK, Moser
AH, Feingold KR et al. Effects of infection and inflammation
on lipid and lipoprotein metabolism: mechanisms and
consequences to the host. J Lipid Res 2004; 45: 1169-96.

Ettinger WH, Varma VK, Sorci-Thomas M, Parks JS, Sigmon
RC, Smith TK et al. Cytokines decrease apolipoprotein
accumulation in medium from Hep G2 cells. Arterioscler
Thromb 1994; 14: 8-13.

19.

Artl A, Marsche G, Lestavel S, Sattler W, Malle E. Role of
serum amyloid A during metabolism of acute-phase HDL-C
by macrophages. Arterioscler Thromb Vasc Biol 2000; 20: 76372.

20.

Lüthold S, Berneis K, Bady P, Müller B. Effects of infectious
disease on plasma lipids and their diagnostic significance in
critical illness. Eur J Clin Inves 2007; 37: 573-579.

21.

Gruber M, Christ-Crain M, Stolz D, Keller U, Müller C,
Bingisser R et al. Prognostic impact of plasma lipids in patients
with lower respiratory tract infections – an observational
study. Swiss Med Wkly 2009; 139: 166-72.

22.

Vermont CL, den Brinker M, Kâkeci N, de Kleijn ED, de
Rijke YB, Joosten KF et al. Serum lipids and disease severity
in children with severe meningococcal sepsis. Crit Care Med
2005; 33: 1610-5.

23.

Deniz O, Tozkoparan E, Yaman H, Cakir E, Gumus S, Ozcan O
et al. Serum HDL-C levels, log (TG/HDL-C. values
and
serum total cholesterol/HDL-C ratios significantly correlate
with radiological extent of disease in patients with communityacquired pneumonia. Clin Biochem 2006; 39: 287-92.

24.

Henter JI, Carlson LA, Hansson M, Nilsson-Ehle P, Ortqvist E.
Lipoprotein alterations in children with bacterial meningitis.
Acta Paediatr 1993; 82: 694-8.

5.

6.

Iribarren C, Jacobs DR, Sidney S, Claxton AJ, Feingold KR.
Cohort study of serum total cholesterol and in-hospital
incidence of infectious diseases. Epidemiol Infect 1998; 121:
335-47.
Emancipator K, Csako G, Elin RJ. In vitro inactivation of
bacterial endotoxin by human lipoproteins and apolipoproteins.
Infect Immun. 1992; 60: 596-601.

7.

Carpentier YA, Scruel O. Changes in the concentration and
composition of plasma lipoproteins during the acute phase
response. Curr Opin Clin Nutr Metab Care 2002; 5: 153-8.

8.

Khovidhunkit W, Memon RA, Feingold KR, Grunfeld C.
Infection and inflammation-induced proatherogenic changes
of lipoproteins. J Infect Dis 2000; 181: 462-472.

9.

Khosla SN, Goyle N, Seth RK. Lipid profile in enteric fever. J
Assoc Phys India 1991; 39: 260-2.

10.

Alvarez C, Ramos A. Lipids, lipoproteins and apoproteins in
serum during infections. Clin Chem 1986; 32: 142-5.

11.

Wu A, Hinds CJ, Thiemermann C. High-density lipoproteins in
sepsis and septic shock: metabolism, actions, and therapeutic
applications. Shock 2004; 21: 210-21.

12.

Sammalkorpi K, Valtonen V, Kerttula Y, Nikkila E, Taskinen
MR. Changes in serum lipoprotein pattern induced by acute
infections. Metabolism 1988; 37: 859-65.

25.

13.

Hardardóttir I, Grünfeld C, Feingold KR. Effects of endotoxin
and cytokines on lipid metabolism. Curr Opin Lipidol 1994; 5:
207-15.

Kerttula Y, Weber T. Serum lipids in pneumonia of different
aetiology. Ann Clin Res 1988; 20:184-8.

26.

14.

Fraunberger P, Schaefer S, Werdan K, Walli AK, Seidel D.
Reduction of circulating cholesterol and apolipoprotein levels
during sepsis. Clin Chem Lab Med 1999; 37: 357-62.

Iscan A, Yigitoglu R, Onag A, Vurgun N, Ari Z, Ertan P et al.
Should children with infection be tested for lipid, lipoprotein
and apolipoprotein? Acta Paediatr Jpn 1998; 40: 47-51.

27.

15.

Kaminska M, Badzio T, Ksiezopolska-Kaczorowska A, Bako W,
Boj E, Przymanowski Z. High-molecular-weight lipoprotein
concentrations in pneumonia in children. Problem Med Wieku
Rozwoj 1983; 12: 363-75.

Gordon BR, Parker TS, Levine DM, Saal SD, Wang JC, Sloan BJ
et al. Low lipid concentrations in critical illness: implications
for preventing and treating endotoxemia. Crit Care Med 1996;
24: 584-9.

469

